Strategically Integrating Automation from Manual Processes to Avoid Pitfalls & Balance Custom Development with Existing Technologies
- Addressing the cell therapy automation paradox by determining optimal implementation timing since fully automated closed systems remain expensive and impractical for early research-scale development
- Balancing custom automation development versus leveraging existing unit operation technologies to avoid reinventing the wheel while maintaining regulatory and business viability
- Securing full organizational buy-in and strategic planning upfront to prevent late-stage automation failures from agency requirements or internal business challenges after significant investment